Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.33 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.33 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.33 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.33 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.33 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.33 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.33 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.33 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.33 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.33 |
| ▸ | PSMB4 | P28070 | 1/20 | 0.33 |
| ▸ | PSMB6 | P28072 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.33 |
| ▸ | PSMB3 | P49720 | 1/20 | 0.33 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.33 |
| ▸ | PSMA6 | P60900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9214351 | 0.98 | EPHX1 (0.41) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL4450962 | 0.98 | EPHX1 (0.41) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL9474195 | 0.98 | EPHX1 (0.41) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL27513432 | 0.98 | EPHX1 (0.41) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL9591949 | 0.94 | CYP1A2 (0.40) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL4942389 | 0.93 | — | — | |
| SCHEMBL5688099 | 0.92 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL9950636 | 0.92 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL9980541 | 0.92 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL7201664 | 0.92 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1PSMB11PSMA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082287-B1 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS | FIRMENICH & CIE (CH) | 2004-03-17 | — | — | EP | disclosed |
| US-6492323-B2 | CONTROLLED RELEASE UPON EXPOSURE TO LIGHT | FIRMENICH SA (CH) | 2002-12-10 | — | — | US | disclosed |
| US-20010014661-A1 | Slow release of fragrant compounds in perfumery using alpha-keto esters | FIRMENICH SA (CH) | 2001-08-16 | — | — | US | disclosed |
| US-6218355-B1 | FOR RELEASING FRAGRANT COMPOUND OR COMPOUNDS IN A CONTROLLED MANNER, MAINTAINING A DESIRED SMELL OVER A PROLONGED PERIOD OF TIME | FIRMENICH SA (CH) | 2001-04-17 | — | — | US | disclosed |
| EP-1082287-A2 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS | FIRMENICH SA (CH) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999060990-A2 | SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR α-KETO ESTERS | FIRMENICH S.A. (CH) | 1999-12-02 | — | — | WO | disclosed |
| EP-0339046-B1 | LEUKOTRIENE B 4 ANALOGS | UPJOHN CO (US) | 1995-02-15 | — | — | EP | disclosed |
| US-5116981-A | Antiinflammatory leukotriene B4 analogs | THE UPJOHN COMPANY (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0234485-B1 | SUBSTITUTED THIENOIMIDAZOLE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS GASTRIC SECRETION INHIBITORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-04-01 | — | — | EP | disclosed |
| US-5053526-A | Platelet aggregation, hypotensive agents, vasodilators and antiulcer agents | MITSUBISHI KASEI CORPORATION (JP) | 1991-10-01 | — | — | US | disclosed |
| US-3969381-A | 13,14-Dihydro-16-fluoro prostaglandin B1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969379-A | 13,14-Dihydro-16-fluoro prostaglandin A1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969380-A | 16-Fluoro prostaglandin F2 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969376-A | 13,14-Dihydro-16-fluoro prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969377-A | 16-Fluoro prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3965118-A | Lactone intermediates | THE UPJOHN COMPANY (US) | 1976-06-22 | — | — | US | disclosed |
| US-3962293-A | 13,14-Dihydro-16-fluoro prostaglandin F1 | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3954835-A | 4,5-Cis-didehydro-PGF1 compounds | THE UPJOHN COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3933889-A | 4,5-Cis-didehydro-PGF1.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931279-A | 5-Oxa prostaglandin F2.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014661-A1 | Slow release of fragrant compounds in perfumery using alpha-keto esters | FAAH, KHK, FAAH2 | EPHX1 203/4885CYP1A2 258/4885ALDH1A1 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.